mRNA Cancer Vaccine Shows Promise in Preventing Melanoma Recurrence
Researchers have reported encouraging results from a large clinical trial evaluating a personalized mRNA-based cancer vaccine designed to prevent melanoma from recurring after surgical removal of the tumor.
The vaccine, developed using messenger RNA technology similar to that employed in certain COVID-19 vaccines, is customized for each patient based on